Tech Company Financing Transactions
LTZ Therapeutics Funding Round
Qiming Ventures, K2 Venture Capital and ShunWei Capital participated in a $10 million Series A funding round for LTZ Therapeutics. The round closed on 5/31/2023.
Transaction Overview
Company Name
Announced On
5/31/2023
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors
Proceeds Purpose
The proceeds will be used to continue establishing the company's platform and pipeline and building LTZ's global operations team.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1100 Island Dr. 103
Redwood City, 94065
USA
Redwood City, 94065
USA
Phone
Undisclosed
Website
Email Address
Overview
LTZ Therapeutics is an immunotherapy-focused biotech company pursuing the development of novel therapies to improve clinical outcomes in patients with cancer and other diseases with an unmet clinical need. LTZ is focused on leveraging the power of innate immunity (e.g., macrophages) and elimination of immunosuppression (e.g., T regulatory cells, cancer-associated fibroblasts) as these areas have been shown to offer tremendous potential for developing innovative and effective therapies. Specifically, LTZ is developing its own novel innate engager platform to effectively activate macrophages in addition to natural killing (NK) cells as effectors to deliver direct anti-tumor and anti-immunosuppressive cell killing and promote inflammation in the tumor microenvironment -- indirectly resulting in activated adaptive immunity and long-term memory.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Li
Chief Scientific Officer
Martin Treder
Co-Founder
Jianhui Zhou
Browse more venture capital transactions:
Prev: 5/31/2023: Builder Prime venture capital transaction
Next: 5/31/2023: Hubble Network venture capital transaction
Share this article
News on VC Transactions
We do our best to record all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs